Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis
暂无分享,去创建一个
M. D. de Bruin‐Weller | F. van Wijk | T. Rispens | M. de Graaf | J. Drylewicz | L. Spekhorst | D. Bakker | J. Thijs | M. Schuttelaar | L. Loman | G. Romeijn | F. Loeff | Celeste M Boesjes | C. Boesjes